Search Results - "COPELAN, Edward"

Hematopoietic Stem-Cell Transplantation by Copelan, Edward A

“…Hematopoietic stem-cell transplantation, which is used to treat both malignant and nonmalignant conditions, was first conceived more than 50 years ago, but…”
Get full text

Allogeneic hematopoietic cell transplantation; the current renaissance by Copelan, Edward A., Chojecki, Aleksander, Lazarus, Hillard M., Avalos, Belinda R.

“…Allogeneic hematopoietic cell transplantation (HCT) provides the best chance for cure for many patients with malignant and nonmalignant hematologic disorders…”
Get full text

CAR T-Cell Therapy in Non-Hodgkin Lymphoma Patients by Copelan, Edward A

Get more information

Concise Review: The Role of Hematopoietic Stem Cell Transplantation in the Treatment of Acute Myeloid Leukemia by Hamilton, Betty K., Copelan, Edward A.

“…Allogeneic hematopoietic stem cell transplantation (HSCT) is a potentially curative option for patients with acute myeloid leukemia (AML). Our understanding of…”
Get full text

Equal access to care and nurse navigation leads to equitable outcomes for minorities with aggressive large B-cell lymphoma by Hu, Bei, Boselli, Danielle, Pye, Lisa M, Chen, Tommy, Bose, Rupali, Symanowski, James T, Blackley, Kris, Moyo, Tamara K, Jacobs, Ryan, Park, Steven I, Soni, Amy, Avalos, Belinda R, Copelan, Edward A, Raghavan, Derek, Ghosh, Nilanjan

“…Aggressive large B-cell lymphomas (LBCLs) are curable, but previous studies have shown inferior outcomes in minorities. Nurse navigation programs can improve…”
Get full text

Incidence, Risk Factors for and Outcomes of Transplant‐Associated Thrombotic Microangiopathy by Epperla, Narendranath, Li, Ang, Logan, Brent, Fretham, Caitrin, Chhabra, Saurabh, Aljurf, Mahmoud, Chee, Lynette, Copelan, Edward, Freytes, César O., Hematti, Peiman, Lazarus, Hillard M., Litzow, Mark, Nishihori, Taiga, Olsson, Richard F., Prestidge, Tim, Saber, Wael, Wirk, Baldeep, Yared, Jean A., Loren, Alison, Pasquini, Marcelo, Abraham, Allistair A., Agrawal, Vaibhav, Aljurf, Mahmoud, Askar, Medhat, Barba, Pere, Bertaina, Alice, Cahn, Jean‐Yves, Cerny, Jan, Choe, Hannah K., Diaz, Miguel Angel, Dvorak, Christopher, Farhadfar, Nosha, Gadalla, Shahinaz M., Gergis, Usama, Ganguly, Siddhartha, Hashmi, Shahrukh, Kasow, Kimberly A., Nathan, Sunita, Nusrat, Roomi, Seo, Sachiko, Shah, Niketa C.

“…Summary Transplant‐associated thrombotic microangiopathy (TA‐TMA) is a complication of allogeneic transplantation (allo‐HCT). The incidence and risk factors…”
Get full text

Navigating the nexus of MRD and novel agents in ALL by Advani, Anjali S, Copelan, Edward A

“…The landscape of acute lymphoblastic leukemia (ALL) has evolved significantly over the last few years. Identification of specific recurrent genetic alterations…”
Get full text

Hematopoietic Stem-Cell Transplantation for Acute Leukemia in Relapse or Primary Induction Failure by DUVAL, Michel, KLEIN, John P, KEATING, Armand, LAZARUS, Hillard M, LITZOW, Mark R, MARKS, David I, MAZIARZ, Richard T, RIZZIERI, David A, SCHILLER, Gary, SCHULTZ, Kirk R, TALLMAN, Martin S, WEISDORF, Daniel, WENSHENG HE, CAHN, Jean-Yves, CAIRO, Mitchell, CAMITTA, Bruce M, KAMBLE, Rammurti, COPELAN, Edward, DE LIMA, Marcos, GUPTA, Vikas

“…Patients with acute leukemia refractory to induction or reinduction chemotherapy have poor prognoses if they do not undergo hematopoietic stem-cell…”
Get full text

Time from diagnosis to treatment initiation predicts survival in younger, but not older, acute myeloid leukemia patients by Sekeres, Mikkael A., Elson, Paul, Kalaycio, Matt E., Advani, Anjali S., Copelan, Edward A., Faderl, Stefan, Kantarjian, Hagop M., Estey, Elihu

“…Acute myeloid leukemia (AML) is considered an oncologic emergency. Delaying induction chemotherapy until molecular testing results return, may benefit some…”
Get full text

Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI by Copelan, Edward A., Hamilton, Betty K., Avalos, Belinda, Ahn, Kwang Woo, Bolwell, Brian J., Zhu, Xiaochun, Aljurf, Mahmoud, van Besien, Koen, Bredeson, Christopher, Cahn, Jean-Yves, Costa, Luciano J., de Lima, Marcos, Gale, Robert Peter, Hale, Gregory A., Halter, Joerg, Hamadani, Mehdi, Inamoto, Yoshihiro, Kamble, Rammurti T., Litzow, Mark R., Loren, Alison W., Marks, David I., Olavarria, Eduardo, Roy, Vivek, Sabloff, Mitchell, Savani, Bipin N., Seftel, Matthew, Schouten, Harry C., Ustun, Celalettin, Waller, Edmund K., Weisdorf, Daniel J., Wirk, Baldeep, Horowitz, Mary M., Arora, Mukta, Szer, Jeff, Cortes, Jorge, Kalaycio, Matt E., Maziarz, Richard T., Saber, Wael

“…Cyclophosphamide combined with total body irradiation (Cy/TBI) or busulfan (BuCy) are the most widely used myeloablative conditioning regimens for…”
Get full text

SF3B1 haploinsufficiency leads to formation of ring sideroblasts in myelodysplastic syndromes by Visconte, Valeria, Rogers, Heesun J., Singh, Jarnail, Barnard, John, Bupathi, Manoj, Traina, Fabiola, McMahon, James, Makishima, Hideki, Szpurka, Hadrian, Jankowska, Anna, Jerez, Andres, Sekeres, Mikkael A., Saunthararajah, Yogen, Advani, Anjali S., Copelan, Edward, Koseki, Haruhiko, Isono, Kyoichi, Padgett, Richard A., Osman, Sami, Koide, Kazunori, O'Keefe, Christine, Maciejewski, Jaroslaw P., Tiu, Ramon V.

“…Whole exome/genome sequencing has been fundamental in the identification of somatic mutations in the spliceosome machinery in myelodysplastic syndromes (MDSs)…”
Get full text

Antimicrobial de-escalation in adult hematopoietic cell transplantation recipients with febrile neutropenia of unknown origin by Petteys, Megan M, Kachur, Ekaterina, Pillinger, Kelly E, He, Jiaxian, Copelan, Edward A, Shahid, Zainab

“…Background The optimal duration of empiric antimicrobial therapy in febrile neutropenia of unknown origin is unclear. This study evaluated outcomes in…”
Get full text

Optimization of physician and specialty pharmacy clinical workflow in assessment of risk category and symptom burden in patients with myelofibrosis (MF) by Chojecki, Aleksander L., DiSogra, Kristyn Y., Arnall, Justin, Cowgill, Nicole, Soni, Amy, Packman, Charles H., Sanikommu, Srinivasa Reddy, Shah, Nilay A., Ragon, Brittany K., Knight, Thomas G., Ai, Jing, Avalos, Belinda R., Copelan, Edward A., Grunwald, Michael R.

Get full text

Curative potential of chemoimmunotherapy in diffuse large B cell lymphoma with hepatic and/or renal dysfunction by Ghosh, Nilanjan, Sanikommu, Srinivasa, Robinson, Myra, Trivedi, Jigar, Brown, Taylor, Bose, Rupali, Park, Steven I., Avalos, Belinda R., Copelan, Edward A., Jacobs, Ryan, Hu, Bei

Get full text

Single nucleotide polymorphism array lesions, TET2, DNMT3A, ASXL1 and CBL mutations are present in systemic mastocytosis by Traina, Fabiola, Visconte, Valeria, Jankowska, Anna M, Makishima, Hideki, O'Keefe, Christine L, Elson, Paul, Han, Yingchun, Hsieh, Fred H, Sekeres, Mikkael A, Mali, Raghuveer Singh, Kalaycio, Matt, Lichtin, Alan E, Advani, Anjali S, Duong, Hien K, Copelan, Edward, Kapur, Reuben, Olalla Saad, Sara T, Maciejewski, Jaroslaw P, Tiu, Ramon V

“…We hypothesized that analysis of single nucleotide polymorphism arrays (SNP-A) and new molecular defects may provide new insight in the pathogenesis of…”
Get full text

Outcomes and hospitalization patterns of patients with acute myelogenous leukemia treated with frontline CPX-351 or HMA/venetoclax by Chojecki, Aleksander L., Arnall, Justin, Boselli, Danielle, Patel, Rushil, Chiad, Zane, DiSogra, Kristyn Y., Karabinos, Allison, Chen, Tommy, Cruz, Adilen, Verbyla, Allison, Ai, Jing, Knight, Thomas G., Ragon, Brittany K., Shah, Nilay A., Sanikommu, Srinivasa R., Symanowski, James, Avalos, Belinda R., Copelan, Edward A., Grunwald, Michael R.

Get full text

Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy by Deeg, H. Joachim, O'Donnell, Margaret, Tolar, Jakub, Agarwal, Rajni, Harris, Richard E., Feig, Stephen A., Territo, Mary C., Collins, Robert H., McSweeney, Peter A., Copelan, Edward A., Khan, Shakila P., Woolfrey, Ann, Storer, Barry

“…In 87 patients with aplastic anemia who failed to respond to immunosuppressive treatment, we determined the minimal dose of total body irradiation (TBI)…”
Get full text

Allogeneic Hematopoietic Cell Transplantation for Fanconi Anemia in Patients With Pretransplantation Cytogenetic Abnormalities, Myelodysplastic Syndrome, or Acute Leukemia by AYAS, Mouhab, SABER, Wael, AL-SERAIHY, Amal, BATTIWALLA, Minoo, CAMITTA, Bruce M, OLSSON, Richard, BAJWA, Rajinder S, BONFIM, Carmem M, PASQUINI, Ricardo, MACMILLAN, Margaret L, GEORGE, Biju, COPELAN, Edward A, DAVIES, Stella M, WIRK, Baldeep, AL JEFRI, Abdullah, FASTH, Anders L, GUINAN, Eva C, HORN, Biljana N, LEWIS, Victor A, SLAVIN, Shimon, STEPENSKY, Polina, BIERINGS, Marc, GALE, Robert Peter, HARRIS, Richard E, HALE, Gregory A, SOCIE, Gerard, LERADEMACHER, Jennifer, THAKAR, Monica, JOACHIM, H, DEEG, J

“…Allogeneic hematopoietic cell transplantation (HCT) can cure bone marrow failure in patients with Fanconi anemia (FA). Data on outcomes in patients with…”
Get full text

COVID-19 vaccine uptake trends in SARS-CoV-2 previously infected cancer patients by Shahid, Zainab, Patrick, Alicia L., Wallander, Michelle L., Donahue, Erin E., Trufan, Sally J., Tan, Antoinette R., Hwang, Jimmy J., Burgess, Earle F., Ragon, Brittany, Ghosh, Nilanjan, Grunwald, Michael R., Voorhees, Peter M., Copelan, Edward A., Raghavan, Derek

“…•Assessment of COVID-19 vaccination rate in a vulnerable patient population.•COVID-19 vaccine uptake among SARS-CoV-2 previously infected cancer patients is…”
Get full text

Tacrolimus/methotrexate vs tacrolimus/reduced-dose methotrexate/mycophenolate for graft-versus-host disease prevention by Hamilton, Betty K., Rybicki, Lisa A., Li, Hong, Lucas, Taylor, Corrigan, Donna, Kalaycio, Matt, Sobecks, Ronald, Hanna, Rabi, Rotz, Seth J., Dean, Robert M., Gerds, Aaron T., Jagadeesh, Deepa, Brunstein, Claudio, Sauter, Craig S., Copelan, Edward A., Majhail, Navneet S.

“…•Compared with full-MTX, mini-MTX/MMF was associated with no significant differences in GVHD.•Mini-MTX was associated with faster engraftment, less mucositis,…”
Get full text